Selecting patients for therapy with a HER inhibitor

Details for Australian Patent Application No. 2005314127 (hide)

Owner Genentech, Inc.

Inventors Januario, Thomas E.; Amler, Lukas C.

Agent Griffith Hack

Pub. Number AU-A-2005314127

PCT Pub. Number WO2006/063042

Priority 60/633,941 07.12.04 US

Filing date 6 December 2005

Wipo publication date 15 June 2006

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

31 May 2007 PCT application entered the National Phase

  PCT publication WO2006/063042 Priority application(s): WO2006/063042

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005314133-Ibudilast for treating neuropathic pain and associated syndromes

2005314124-3, 6-bicyclolides